Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.20 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $127.57 million which missed the analyst consensus estimate of $130.34 million by 2.12 percent. This is a 1.94 percent increase over sales of $125.14 million the same period last year.
Jefferies Initiates Coverage On Allstate with Hold Rating, Announces Price Target of $121
Jefferies analyst Yaron Kinar initiates coverage on Allstate (NYSE:ALL) with a Hold rating and announces Price Target of $121.